Dysfunction at the vascular–endothelial interface is increasingly relevant here, especially considering reports of abnormal vascular endothelial growth factor (VEGF) in treatment-refractory depression [58,59,60,61,62,63,64]. Here, VEGFA is linked to major depressive disorder.